Point72 Middle East FZE’s Mersana Therapeutics MRSN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,020
Closed -$59.2K 619
2023
Q4
$59.2K Buy
1,020
+46
+5% +$2.67K ﹤0.01% 727
2023
Q3
$30.9K Buy
+974
New +$30.9K ﹤0.01% 765
2023
Q2
Sell
-639
Closed -$65.7K 1345
2023
Q1
$65.7K Buy
639
+256
+67% +$26.3K ﹤0.01% 683
2022
Q4
$56.1K Buy
+383
New +$56.1K ﹤0.01% 888